Alvarez & Marsal Taxand Managing Director, Al Liguori, was quoted in the Bloomberg.com article “AbbVie Moves Allergan Profits to U.S. in Partial GOP Tax Law Win.”

"The 2017 tax overhaul cut the rate from 35% to 21% and killed off nearly all remaining reasons for companies to invert. But Allergan will likely have to pay a new tax in the law on what is known as global intangible low-taxed income, or GILTI, said Albert W. Liguori, managing director at consulting firm Alvarez & Marsal Taxand."

Click here to read the full article. 

This article was originally published on Bloomberg.com on June 26^th. ©2019 Bloomberg L.P.